يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Morgillo F."', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

    المؤلفون: Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C., GEBBIA, Vittorio, SPATAFORA, Mario

    المساهمون: Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C

    مصطلحات موضوعية: Questionnaire, Neoplasm Staging, Human, Salvage Therapy, Prognosi, Quality of Life, Aged, Quinazoline, Research Design, Cisplatin, Deoxycytidine, Lung Neoplasm, Carcinoma, Large Cell, Antineoplastic Combined Chemotherapy Protocol, Follow-Up Studie, Neoplasm Recurrence, Local, Adenocarcinoma, Squamous Cell, Non-Small-Cell Lung, Male, Female

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/PMID: 23154555; info:eu-repo/semantics/altIdentifier/wos/WOS:000311387700022; volume:7; issue:12; firstpage:1830; lastpage:1844; numberofpages:15; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/10447/80043Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84870327842

    الإتاحة: https://doi.org/10.1097/JTO.0b013e318275b327Test
    http://hdl.handle.net/10447/80043Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials.

    المؤلفون: Gridelli, C, Morabito, A, Mencoboni, M, Carrozza, F, Viganò, MG, Verusio, C, Bollina, R, Mattioli, R, Valmadre, G, Maione, P, Rossi, A, Cascone, T, Morgillo, F, Di Maio, M, Piccirillo, MC, Gallo, C, Perrone, F, Ciardiello, F., GEBBIA, Vittorio, VALERIO, Maria Rosaria

    المساهمون: Gridelli, C, Morabito, A, Gebbia, V, Mencoboni, M, Carrozza, F, Viganò, MG, Verusio, C, Bollina, R, Mattioli, R, Valerio, MR, Valmadre, G, Maione, P, Rossi, A, Cascone, T, Morgillo, F, Di Maio, M, Piccirillo, MC, Gallo, C, Perrone, F, Ciardiello, F

    مصطلحات موضوعية: NSCLC, Elderly patient, PS2 patient, Gemcitabine, Cetuximab, Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000273878300013; volume:67; firstpage:86; lastpage:92; numberofpages:7; journal:LUNG CANCER; http://hdl.handle.net/10447/47504Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-71849107743

    الإتاحة: https://doi.org/10.1016/j.lungcan.2009.03.021Test
    http://hdl.handle.net/10447/47504Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث